{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T06:26:12Z","timestamp":1776839172001,"version":"3.51.2"},"reference-count":38,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.acvd.2015.03.009","type":"journal-article","created":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T01:26:49Z","timestamp":1435022809000},"page":"385-397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Fully bioresorbable drug-eluting coronary scaffolds: A review"],"prefix":"10.1016","volume":"108","author":[{"given":"Emmanuel","family":"Charpentier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Barna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lo\u00efc","family":"Guillevin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Michel","family":"Juliard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2015.03.009_bib0195","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0002-8703(81)90190-3","article-title":"Efficacy of percutaneous transluminal coronary angioplasty: technique, patient selection, salutary results, limitations and complications","volume":"101","author":"Cowley","year":"1981","journal-title":"Am Heart J"},{"key":"10.1016\/j.acvd.2015.03.009_bib0200","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1056\/NEJM198704303161805","article-title":"Long-term follow-up after percutaneous transluminal coronary angioplasty. The early Zurich experience","volume":"316","author":"Gruentzig","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2015.03.009_bib0205","first-page":"IV92","article-title":"Intracoronary stenting during percutaneous transluminal coronary angioplasty","volume":"81","author":"Roubin","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2015.03.009_bib0210","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1161\/01.CIR.0000025585.63486.59","article-title":"Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial","volume":"106","author":"Serruys","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2015.03.009_bib0215","first-page":"103","article-title":"Novel drug-eluting stents in the treatment of de novo coronary lesions","volume":"7","author":"Capodanno","year":"2011","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.acvd.2015.03.009_bib0220","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1586\/erc.09.33","article-title":"Evolution of stents: past, present and future","volume":"7","author":"Tamburino","year":"2009","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.acvd.2015.03.009_bib0225","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(12)61962-X","article-title":"Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial","volume":"381","author":"Christiansen","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2015.03.009_bib0230","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2010.06.008","article-title":"Coronary stents: looking forward","volume":"56","author":"Garg","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2015.03.009_bib0235","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/heartjnl-2012-303346","article-title":"Bioabsorbable scaffolds for the treatment of obstructive coronary artery disease: the next revolution in coronary intervention?","volume":"99","author":"Patel","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.acvd.2015.03.009_bib0240","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/eurheartj\/eht542","article-title":"Bioresorbable scaffolds: rationale, current status, challenges, and future","volume":"35","author":"Iqbal","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2015.03.009_bib0245","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1161\/CIRCULATIONAHA.110.000901","article-title":"Long-Term (>10years) clinical outcomes of first-in-human biodegradable poly-l-lactic acid coronary stents: Igaki-Tamai stents","volume":"125","author":"Nishio","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2015.03.009_bib0250","first-page":"37","article-title":"Bioresorbable scaffolds in the treatment of coronary artery disease","volume":"6","author":"Zhang","year":"2013","journal-title":"Med Devices"},{"key":"10.1016\/j.acvd.2015.03.009_bib0255","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.CIR.102.4.399","article-title":"Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans","volume":"102","author":"Tamai","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2015.03.009_bib0260","series-title":"Elixir medical announces enrollment completion of the DESolve Nx Pivotal Trial for fully bioresorbable coronary scaffold system","author":"Reuters","year":"2012"},{"key":"10.1016\/j.acvd.2015.03.009_bib0265","series-title":"Cardiology Today. DESolve Nx: 6-month results strong for bioresorbable scaffold","year":"2013"},{"key":"10.1016\/j.acvd.2015.03.009_bib0270","series-title":"Business Wire. Arterial Remodeling Technologies (\u2018ART\u2019) reports 30-day results for the \u2018ARTDIVA\u2019 clinical trial of its next-generation bioresorbable stent at \u2018TCT 2013\u2019 annual scientific meeting","year":"2013"},{"key":"10.1016\/j.acvd.2015.03.009_bib0275","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0140-6736(12)61765-6","article-title":"Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12-month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial","volume":"381","author":"Haude","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2015.03.009_bib0280","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jcin.2008.09.015","article-title":"Early- and long-term intravascular ultrasound and angiographic findings after bioabsorbable magnesium stent implantation in human coronary arteries","volume":"2","author":"Waksman","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.acvd.2015.03.009_bib0285","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0140-6736(09)60325-1","article-title":"A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods","volume":"373","author":"Serruys","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2015.03.009_bib0290","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/heartjnl-2012-302598","volume":"99","author":"Diletti","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.acvd.2015.03.009_bib0295","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jacc.2011.02.052","article-title":"6-month clinical outcomes following implantation of the bioresorbable everolimus-eluting vascular scaffold in vessels smaller or larger than 2.5mm","volume":"58","author":"Diletti","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2015.03.009_bib0300","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.jacc.2011.05.050","article-title":"Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes","volume":"58","author":"Serruys","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2015.03.009_bib0305","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4244\/EIJV10I2A38","article-title":"Procedural and clinical outcomes of the absorb everolimus-eluting bioresorbable vascular scaffold: one-month results of the bioresorbable vascular scaffold evaluated at Rotterdam Cardiology Hospitals (B-SEARCH)","volume":"10","author":"Simsek","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.acvd.2015.03.009_bib0310","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4244\/EIJV10I4A78","article-title":"Lessons learned from acute and late scaffold failures in the ABSORB EXTEND trial","volume":"10","author":"Ishibashi","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.acvd.2015.03.009_bib0315","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jcin.2012.10.013","volume":"6","author":"Muramatsu","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.acvd.2015.03.009_bib0320","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.4244\/EIJV10I12A243","article-title":"The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512\u00a0patients enrolled","volume":"10","author":"Abizaid","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.acvd.2015.03.009_bib0325","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/eurheartj\/eht545","article-title":"Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study \u2018Prague\u00a019\u2019","volume":"35","author":"Kocka","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2015.03.009_bib0330","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/eurheartj\/eht546","article-title":"Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study","volume":"35","author":"Diletti","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2015.03.009_bib0335","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ahj.2012.08.010","volume":"164","author":"Diletti","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.acvd.2015.03.009_bib0340","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(14)61455-0","volume":"385","author":"Serruys","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2015.03.009_bib0345","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ahj.2013.09.017","volume":"167","author":"Woudstra","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.acvd.2015.03.009_bib0350","unstructured":"ClinicalTrials.gov. A service of the U.S. National Institutes of Health [Available at: http:\/\/www.clinicaltrials.gov\/ct2\/home (accessed date: 8th March 2014)]."},{"key":"10.1016\/j.acvd.2015.03.009_bib0355","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jcin.2013.07.007","article-title":"A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results","volume":"7","author":"Verheye","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.acvd.2015.03.009_bib0360","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0140-6736(08)60415-8","article-title":"A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial","volume":"371","author":"Ormiston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2015.03.009_bib0365","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4244\/EIJ30V6I4A76","article-title":"Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial","volume":"6","author":"Onuma","year":"2010","journal-title":"EuroIntervention"},{"key":"10.1016\/j.acvd.2015.03.009_bib0370","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.4244\/EIJV7I9A168","article-title":"Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial","volume":"7","author":"Dudek","year":"2012","journal-title":"EuroIntervention"},{"key":"10.1016\/j.acvd.2015.03.009_bib0375","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jcin.2013.05.017","article-title":"Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial","volume":"6","author":"Onuma","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.acvd.2015.03.009_bib0380","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1161\/CIRCULATIONAHA.110.970772","article-title":"Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes","volume":"122","author":"Serruys","year":"2010","journal-title":"Circulation"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213615001084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213615001084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:42:21Z","timestamp":1761745341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213615001084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":38,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1875213615001084"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2015.03.009","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fully bioresorbable drug-eluting coronary scaffolds: A review","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2015.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}